Comments to FDA: Labeling Requirements for OTC Human Drugs

Share page:
Docket Number:
1998 N-0337C

FDA issued a proposed rule on labeling requirements for OTC human drugs. The announcement proposed a definition for “convenience-size” OTC drug packages as well as the option of alternative labeling requirements for these products. CHPA welcomes the opportunity to comment on the proposed rule changes.

Related Posts